Filed 2.6y ago· Oct 19, 2023
21 days to disclose
Robert J. Wittman
RHouseVirginia-01
↓sold
UnitedHealth Group
UNH
$1K-$15K
+14.5% vs S&P 500
Trade dateSep 28, 2023
Common Stock
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.










| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Oct 19, 2023 2.6y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↓sold | UnitedHealth Group UNH Common Stock | Sep 28, 2023 21 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 15, 2023 3.3y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↑bought | Elevance Health ELV | Jan 20, 2023 26 days to disclose | Bad buy·−$1.4K-17.1% −28.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 15, 2023 3.3y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↓sold | Baxter International BAX | Jan 3, 2023 43 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↑bought | Baxter International BAX | Jul 15, 2022 26 days to disclose | Bad buy·−$5.9K-73.8% −87.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↑bought | Abbott Laboratories ABT | Jul 15, 2022 26 days to disclose | Bad buy·−$1.7K-20.9% −35.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 8, 2022 3.9y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↓sold | Baxter International BAX | Jun 16, 2022 22 days to disclose | Flat·+0.0% +23.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 8, 2022 3.9y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↑bought | Abbott Laboratories ABT | Jun 16, 2022 22 days to disclose | Bad buy·−$1.2K-15.5% −39.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 13, 2022 4.1y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↓sold | Abbott Laboratories ABT | Apr 19, 2022 24 days to disclose | Flat·+0.0% +7.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 9, 2022 4.2y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↑bought | Abbott Laboratories ABT | Mar 29, 2022 11 days to disclose | Bad buy·−$2.3K-28.2% −35.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 9, 2022 4.4y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↓sold | Boston Scientific BSX | Dec 16, 2021 24 days to disclose | price pending | $1K-$15K midpoint $8K |